Presenting the road project, Roads Authority’s Social Planning Officer Boston Kadzamila, said currently, the road is narrow ...

Blantyre - Aids-ravaged Malawi, where over a tenth of the population is HIV positive, records on average 1 000 new cases weekly, a top government official said on Saturday. "It’s a great concern to us ...

JOHANNESBURG, May 14 (Reuters) - Testing and monitoring of HIV patients across South Africa have fallen since the United States cut aid that funded health workers and clinics, with pregnant women ...

May 29, 2025 — New HIV research shows that small changes in the virus affect how quickly or slowly it replicates and how easily it can reawaken in the body. These insights bring researchers ...

Get Instant Summarized Text (Gist) Analysis of large health databases indicates that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used for HIV and hepatitis B, have a ...

UVA Health scientists are calling for clinical trials testing the potential of HIV drugs called NRTIs to prevent Alzheimer's disease after discovering that patients taking the drugs are ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

Laboratory monitoring for HIV disease in resource-limited settings has now become one of the key challenges for access and success, to prevent ART failure and to switch to second- and third-line ...

The Los Angeles LGBT Center says lives are now at risk since funding for HIV prevention has been cut off by the county. In a sharply worded post on Instagram, Joe Hollendoner, the nonprofit’s ...

The Centers for Disease Control and Prevention’s 2022 HIV surveillance report indicates that among cisgender women, Black women accounted for 50% of HIV diagnoses. Among transgender women ...

An interim analysis by the trial's data and safety monitoring committee concluded that "the regimen does not protect against HIV and the study is not expected to meet its primary endpoint." ...

For HIV, researchers are designing antigens that trigger the production of antibodies that can target the MPER region with both protein and lipid specificity, just like bNAbs do.